389 related articles for article (PubMed ID: 19243035)
1. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.
Haacke EM; Makki M; Ge Y; Maheshwari M; Sehgal V; Hu J; Selvan M; Wu Z; Latif Z; Xuan Y; Khan O; Garbern J; Grossman RI
J Magn Reson Imaging; 2009 Mar; 29(3):537-44. PubMed ID: 19243035
[TBL] [Abstract][Full Text] [Related]
2. Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Chawla S; Kister I; Wuerfel J; Brisset JC; Liu S; Sinnecker T; Dusek P; Haacke EM; Paul F; Ge Y
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1223-30. PubMed ID: 27012298
[TBL] [Abstract][Full Text] [Related]
3. Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI.
Grabner G; Dal-Bianco A; Schernthaner M; Vass K; Lassmann H; Trattnig S
J Magn Reson Imaging; 2011 Mar; 33(3):543-9. PubMed ID: 21563237
[TBL] [Abstract][Full Text] [Related]
4. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Höftberger R; Berger T; Auff E; Leutmezer F; Trattnig S; Lassmann H; Bagnato F; Hametner S
Acta Neuropathol; 2017 Jan; 133(1):25-42. PubMed ID: 27796537
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis: validation of MR imaging for quantification and detection of iron.
Walsh AJ; Lebel RM; Eissa A; Blevins G; Catz I; Lu JQ; Resch L; Johnson ES; Emery DJ; Warren KG; Wilman AH
Radiology; 2013 May; 267(2):531-42. PubMed ID: 23297322
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
Wisnieff C; Ramanan S; Olesik J; Gauthier S; Wang Y; Pitt D
Magn Reson Med; 2015 Aug; 74(2):564-70. PubMed ID: 25137340
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.
Sparacia G; Speciale C; Banco A; Bencivinni F; Midiri M
Neuroradiol J; 2016 Oct; 29(5):326-35. PubMed ID: 27549150
[TBL] [Abstract][Full Text] [Related]
8. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility-weighted MR imaging: a better technique in the detection of capillary telangiectasia compared with T2* gradient-echo.
Chaudhry US; De Bruin DE; Policeni BA
AJNR Am J Neuroradiol; 2014 Dec; 35(12):2302-5. PubMed ID: 25147196
[TBL] [Abstract][Full Text] [Related]
10. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
Eissa A; Lebel RM; Korzan JR; Zavodni AE; Warren KG; Catz I; Emery DJ; Wilman AH
J Magn Reson Imaging; 2009 Oct; 30(4):737-42. PubMed ID: 19787716
[TBL] [Abstract][Full Text] [Related]
11. 3D MRI in multiple sclerosis: a study of three sequences at 3 T.
Mills RJ; Young CA; Smith ET
Br J Radiol; 2007 May; 80(953):307-20. PubMed ID: 17005516
[TBL] [Abstract][Full Text] [Related]
12. Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging.
Yao B; Bagnato F; Matsuura E; Merkle H; van Gelderen P; Cantor FK; Duyn JH
Radiology; 2012 Jan; 262(1):206-15. PubMed ID: 22084205
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging.
Lipka A; Bogner W; Dal-Bianco A; Hangel GJ; Rommer PS; Strasser B; Motyka S; Hingerl L; Berger T; Leutmezer F; Gruber S; Trattnig S; Niess E
Neuroimage Clin; 2023; 40():103524. PubMed ID: 37839194
[TBL] [Abstract][Full Text] [Related]
15. Brain iron deposition and sequence characteristics in Parkinsonism: comparison of SWI, T₂* maps, T₂-weighted-, and FLAIR-SPACE.
Rossi M; Ruottinen H; Elovaara I; Ryymin P; Soimakallio S; Eskola H; Dastidar P
Invest Radiol; 2010 Dec; 45(12):795-802. PubMed ID: 20829707
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.
Ge Y; Jensen JH; Lu H; Helpern JA; Miles L; Inglese M; Babb JS; Herbert J; Grossman RI
AJNR Am J Neuroradiol; 2007 Oct; 28(9):1639-44. PubMed ID: 17893225
[TBL] [Abstract][Full Text] [Related]
17. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
[TBL] [Abstract][Full Text] [Related]
18. Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
Teraguchi M; Yamada H; Yoshida M; Nakayama Y; Kondo T; Ito H; Terada M; Kaneoke Y
J Magn Reson Imaging; 2014 Nov; 40(5):1199-207. PubMed ID: 24395471
[TBL] [Abstract][Full Text] [Related]
19. Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.
Hagemeier J; Heininen-Brown M; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Weinstock-Guttman B; Dwyer MG; Zivadinov R
J Magn Reson Imaging; 2012 Jul; 36(1):73-83. PubMed ID: 22407571
[TBL] [Abstract][Full Text] [Related]
20. Blood Perfusion and Cellular Microstructural Changes Associated With Iron Deposition in Multiple Sclerosis Lesions.
Sheng H; Zhao B; Ge Y
Front Neurol; 2019; 10():747. PubMed ID: 31354613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
